Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers http://novacyt.com/wp-content/uploads/2018/10/NOVACYT_CP_Droits-de-vote_2018-Oct.pdf
Visit PageNews and Events
Liquidity Agreement Monthly Update and Total Voting Rights
Paris, France and Camberley, UK – 1 October 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is further summarised
Visit PageNOVACYT HALF YEAR 2018 RESULTS Molecular product revenues up 18% to €3m Gross margin increases to 64%
Novacyt half year 2018 results Paris, France and Camberley, UK – 26 September 2018 – Novacyt (ALTERNEXT: ALNOV; AIM: NCYT), an international specialist in clinical diagnostic products, today announces unaudited financial results for the six months ended 30 June 2018.
Visit Page